TB Testing Services Wales Limited Filleted accounts for Companies House (small and micro)

TB Testing Services Wales Limited Filleted accounts for Companies House (small and micro)


0 false false false false false false true false false true false false false false false false No description of principal activity 2021-05-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 6867505 2021-05-01 2022-04-30 6867505 2022-04-30 6867505 2021-04-30 6867505 bus:OrdinaryShareClass1 2021-05-01 2022-04-30 6867505 bus:Director2 2021-05-01 2022-04-30 6867505 core:WithinOneYear 2022-04-30 6867505 core:WithinOneYear 2021-04-30 6867505 core:ShareCapital 2022-04-30 6867505 core:ShareCapital 2021-04-30 6867505 core:RetainedEarningsAccumulatedLosses 2022-04-30 6867505 core:RetainedEarningsAccumulatedLosses 2021-04-30 6867505 bus:SmallEntities 2021-05-01 2022-04-30 6867505 bus:AuditExemptWithAccountantsReport 2021-05-01 2022-04-30 6867505 bus:FullAccounts 2021-05-01 2022-04-30 6867505 bus:SmallCompaniesRegimeForAccounts 2021-05-01 2022-04-30 6867505 bus:PrivateLimitedCompanyLtd 2021-05-01 2022-04-30 6867505 bus:OrdinaryShareClass1 2022-04-30 6867505 bus:OrdinaryShareClass1 2021-04-30
COMPANY REGISTRATION NUMBER: 6867505
TB Testing Services Wales Limited
Filleted Unaudited Financial Statements
30 April 2022
TB Testing Services Wales Limited
Financial Statements
Year ended 30 April 2022
Contents
Pages
Statement of financial position
1
Notes to the financial statements
2 to 3
TB Testing Services Wales Limited
Statement of Financial Position
30 April 2022
2022
2021
Note
£
£
Creditors: amounts falling due within one year
4
( 1,405)
( 1,405)
-------
-------
Net current liabilities
( 1,405)
( 1,405)
-------
-------
Total assets less current liabilities
( 1,405)
( 1,405)
-------
-------
Capital and reserves
Called up share capital
5
1
1
Profit and loss account
( 1,406)
( 1,406)
-------
-------
Shareholders deficit
( 1,405)
( 1,405)
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 30 April 2022 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 19 December 2022 , and are signed on behalf of the board by:
Mr B Griffin
Director
Company registration number: 6867505
TB Testing Services Wales Limited
Notes to the Financial Statements
Year ended 30 April 2022
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Talgarreg, Graig, Burry Port, SA16 0DG.
2. Statement of compliance
These financial statements have been prepared in accordance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the Companies Act 2006.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders deficit during the current year or prior year.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Creditors: amounts falling due within one year
2022
2021
£
£
Director loan accounts
1,405
1,405
-------
-------
5. Called up share capital
Issued, called up and fully paid
2022
2021
No.
£
No.
£
Ordinary shares of £ 1 each
1
1
1
1
----
----
----
----
6. Related party transactions
The company was under the control of Mr B Griffin and Mrs A Griffin, the directors, during the current and previous year by virtue of their majority shareholdings. No transactions with related parties were undertaken such as are required to be disclosed under FRS 102.